![](https://pharmatimes.com/wp-content/uploads/2023/12/JUNE_Brain.jpg)
MJFF awards $6m to Lario Therapeutics for Parkinson’s research
The neurological disease is estimated to affect more than ten million people globally The Michael J. Fox Foundation (MJFF) has awarded $6m to Lario Therapeutics to fund its preclinical programme for Parkinson’s disease (PD) research. The company will …